The China-America Technology Corp.
Integrating Chinese Technology with American Ideals

Commodities
Lumbrokinase
For Treatment and Prevention of Thrombus and Embolic Diseases


Introduction

Coronary heart disease and cerebrovascular disease are major diseases which endanger human life and health. According to the World HealthOrganization(WHO), the total death toll from Cardiac disease and cerebrovascular disease is about 12 million people all over the world.

Our Technology

Chinese scientists have applied lumbrokinase, a plasminogen activator to solve this problem. This medicine is similar to the tissue plasminogen activator from various sources, which can convert the plasminogen into plasmin to carry out fibrinolysis, thus dissolving fibrin in thrombus.

Lumbrokinase Properties

Long term toxicological tests in experimental animals showed that lumbrokinase is non toxic, free of side effects on the functioning of the heart, liver, kidney, respiratory and nervous systems.

Lumbrokinase is a new thrombolytic medicine, which is safe, non-toxic, with no obvious side-effects, and convenient to use in clinical practice.

Lumbrokinase capsule or powder available from China

Get More Information

TOP THREE RELATED SITES

Spirulina Powder
Pearl Powder
Teapolyphenol

Related Links

Go Back to The Guide to Technologies

We are proud to be affiliated with:

The Chinese Academy of Science
Chinese Academy
of Science

&

The City College of NY
City College of New York

We have access

to 50,000 top

scientists & A Vast

Network of

Business Contacts

throughout China

Technology Transfer | Contract R&D | Manufacturing | Joint Ventures | Technology Alert | Information Services
Welcome Page | Search Page | Technology Listing | Product Listing | Subscription Form | General info Form

Contact CTC:

	China-America Technology Corp.		TEL: +1-212-650-5606
	Marshak Science Bldg., Rm. J423		FAX: +1-212-650-5608
	138th St. at Convent Ave.			
	New York, NY 10031
	
ctc@chinatech.com